Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

InMed Pharmaceuticals (INM) Other Gross PP&E Adjustments: 2021-2025

Historic Other Gross PP&E Adjustments for InMed Pharmaceuticals (INM) over the last 3 years, with Jun 2025 value amounting to $2.3 million.

  • InMed Pharmaceuticals' Other Gross PP&E Adjustments fell 10.55% to $2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $9.4 million, marking a year-over-year decrease of 0.76%. This contributed to the annual value of $2.3 million for FY2025, which is 10.55% down from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Other Gross PP&E Adjustments of $2.3 million as of Q2 2025, which was up 0.45% from $2.3 million recorded in Q1 2025.
  • InMed Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $2.6 million for Q4 2023, and its period low was $549,195 during Q3 2021.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was $2.4 million (2024), whereas its average is $2.2 million.
  • Per our database at Business Quant, InMed Pharmaceuticals' Other Gross PP&E Adjustments spiked by 158.69% in 2022 and then decreased by 10.95% in 2025.
  • InMed Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at $1.4 million in 2021, then grew by 0.25% to $1.4 million in 2022, then skyrocketed by 83.38% to $2.6 million in 2023, then dropped by 8.99% to $2.4 million in 2024, then decreased by 10.55% to $2.3 million in 2025.
  • Its Other Gross PP&E Adjustments stands at $2.3 million for Q2 2025, versus $2.3 million for Q1 2025 and $2.4 million for Q4 2024.